BNO
Click for more information
5.26% 20.0¢ bionomics limited

Ann: BNC105 Clinical Trial In Combination With Nivolumab, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. doubledeckerdog
    707 Posts.
    lightbulb Created with Sketch. 78
    clock Created with Sketch.
    09/01/19
    19:11
    Post #: 37072591
    BNO has been trying to flog this molecule for about five years - this trial is a last gasp attempt to spin a story about a doubtful drug candidate. Prepare to be disappointed!!! The Board is desperately trying to buy time, hoping for a miracle - again!

    GLTA - DYOR
    BNO Price at posting: 12.5¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.